ARCHIVES

O’Shaughnessy, Burris To Present for Genentech At FDA Hearing At June 28-29

This article is from The Cancer Letter archive.

Vol. 37 No. 23 | June 10, 2011

Download PDF Visit The Full Archive

Related Articles

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

November 29, 2013

FOCR Report Offers Recommendations, Definitions for CER

May 22, 2009

Other ASCO Plenary Papers: Long Awaited Chemotherapy Results

June 12, 1992

NCAB Oks LANs To Links NCI Staff With Each Other, The World

February 14, 1992

Rising Costs at NCI Threaten To Overtake Slim Increases In Budget Appropriations

March 28, 2014